Sl. Geh et al., IDENTIFICATION OF PHOSPHOLIPASE A(2) AND NEUROTOXIC ACTIVITIES IN THEVENOM OF THE NEW GUINEAN SMALL-EYED SNAKE (MICROPECHIS-IKAHEKA), Toxicon, 35(1), 1997, pp. 101-109
S. L. Geh, A. Vincent, S. Rang, T. Abrahams, L. Jacobson, B. Lang and
D. Warrell. Identification of phospholipase A(2) and neurotoxic activi
ties in the venom of the New Guinean small-eyed snake (Micropechis ika
heka). Toxicon 35, 101-109, 1997.-The Papua New Guinean small-eyed sna
ke (Micropechis ikaheka) is recognised as a cause of life-threatening
envenoming in certain parts of New Guinea. The clinical features sugge
st the presence of toxins acting at the neuromuscular junction and on
muscle. We have used the mouse phrenic nerve-hemidiaphragm preparation
, a phospholipase A(2) assay, and I-125-neurotoxin-binding radioimmuno
assays to look for toxic activities in the crude venom and in prelimin
ary high-performance liquid chromatography(HPLC) fractions. Micropechi
s ikaheka venom at 1 and 3 mu g/ml completely abolished nerve-evoked m
uscle twitch within 70 min at 37 degrees C. There was also a sustained
contracture of the muscle and some reduction in twitch tension evoked
by direct stimulation; these were explained by the presence of phosph
olipase A(2) activity. The venom inhibited the binding of I-125-alpha-
bungarotoxin to detergent-extracted human muscle acetylcholine recepto
r (AChR), and inhibited acetylcholine receptor function in a muscle ce
ll line. It also inhibited binding of I-125-omega-conotoxin GVIA to de
tergent-extracted human frontal cortex voltage-gated calcium channels,
but this appeared to be dependent on the phospholipase A(2) activity.
Identification of the main neurotoxic fractions following HPLC are sh
own. Copyright (C) 1996 Elsevier Science Ltd.